Bladder cancer is one of the most common cancers in the world. Non-muscle invasive bladder cancer (NMIBC) is a precursor that, when caught early, can give patients an incredibly favorable prognosis.

Bladder cancer remains a major public health burden in the United States. The American Cancer Society estimates 84,870 new cases of bladder cancer and 17,420 deaths annually in the United States, ...

NMIBC treatment varies by tumor stage, grade, and prior therapies, with high-risk cases often requiring radical cystectomy. Bladder-preserving approaches include intravesical therapies like BCG, ...

Muscle invasive bladder cancer (MIBC) is a type of transitional cell carcinoma that originates from the urothelium and gradually invades the detrusor muscle of the urinary bladder. MIBC is an advanced ...

There is increasing interest in trimodality therapy (TMT) to provide bladder preservation for patients with urothelial muscle-invasive bladder cancer (MIBC) as an alternative to radical cystectomy (RC ...

Non-muscle invasive bladder cancer is cancer that’s only in the inner lining of your bladder. It hasn’t grown into the muscle wall. Your doctor may also call it superficial bladder cancer, urothelial ...

A 27-year-old Hispanic man presents to an emergency department in New Jersey in August 2014 after seeing blood in his urine earlier that day. He tells clinicians that although he has no trouble ...

Bladder wall thickening can result from urinary tract infections (UTIs), bladder outlet obstruction (BOO), benign or cancerous tumors, or chronic inflammation. It happens when the bladder works harder ...

Muscle invasive bladder cancer (MIBC) is an advanced stage of bladder cancer that invades the smooth muscle lining of the bladder. Bladder cancer typically originates in the urothelium, which is a ...